Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma
Add to one of your playbooks
Loading your playbooks…
Abstract
Surgery is the cornerstone of therapy for hepatoblastoma (HB). While standard resection (SR) via hemi-hepatectomy and trisectionectomy has traditionally been the preferred surgical approach, parenchyma-sparing resection (PSR) has become increasingly popular. We sought to compare the characteristics and outcomes of patients who underwent PSR versus SR.
This article is published on an external journal. Click below to read the full text.
Read full article ↗How to cite: GlobalCastMD. Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma. GlobalCastMD Medical Library. 2026-05-05. https://origin-library.globalcastmd.com/article/12001?via_space=staycurrentmd
Comments (0)